The J. M. Smucker Company (NYSE:SJM) reported Net sales increased $533.9 million, or 37 percent, reflecting the contribution of Big Heart Pet Brands (“Big Heart”), acquired in fiscal 2015. Net income per diluted share was $1.55, a decrease of 2 percent, as the benefit from Big Heart operations and the gain on the U.S. canned milk divestiture were offset by merger and integration costs, higher interest expense, and the impact of additional shares outstanding.
The J. M. Smucker Company (NYSE:SJM) belongs to Consumer Goods sector. Its net profit margin is 5.50% and weekly performance is -0.06%. On last trading day company shares ended up at $127.67. The J. M. Smucker Company (NYSE:SJM) distance from 50-day simple moving average (SMA50) is 3.25%.
Omeros Corporation (NASDAQ:OMER), announced further expansion of its OMS721 compassionate use program to Finland. OMS721 is Omeros’ lead human monoclonal antibody in its mannan-binding lectin-associated serine protease-2 (MASP-2) program for the treatment of thrombotic microangiopathies (TMAs), including atypical hemolytic uremic syndrome (aHUS).
Omeros Corporation (NASDAQ:OMER) shares moved down -0.59% in last trading session and ended the day at $10.10. OMER Gross Margin is 91.40% and its return on assets is -163.40%. Omeros Corporation (NASDAQ:OMER) quarterly performance is -31.11%.
Delphi Automotive PLC (NYSE:DLPH) present at Barclays Industrial Select Conference on Feb. 18 in Miami Beach, Fla. Delphi’s Chief Technology Officer, Jeff Owens presented at 1:35 p.m. ET.
On 26 February, Delphi Automotive PLC (NYSE:DLPH) shares increased 0.06% and was closed at $66.72. DLPH EPS growth in last 5 year was 16.60%. Delphi Automotive PLC (NYSE:DLPH) year to date (YTD) performance is -21.79%.
On 24 February, Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announced that it is embarking on a strategic enterprise-wide corporate identity program to build a global brand. This is the manifestation of the journey Teva embarked on two years ago, to differentiate itself based on the unique characteristics of the Company’s business model and create a new breed of healthcare company.
Teva Pharmaceutical Industries Limited (NYSE:TEVA) ended the last trading day at $56.98. Company weekly volatility is calculated as 1.77% and price to cash ratio as 8.55. Teva Pharmaceutical Industries Limited (NYSE:TEVA) showed a weekly performance of 1.22%.
Acorn International, Inc. (NYSE:ATV) shares moved down -8.43% in last trading session and ended the day at $5.54. ATV Gross Margin is 40.00% and its return on assets is -31.30%. Acorn International, Inc. (NYSE:ATV) quarterly performance is 73.13%.